M&A Deal Summary

Kent Pharma Acquires Athlone Laboratories

On June 5, 2019, Kent Pharma acquired life science company Athlone Laboratories

Acquisition Highlights
  • This is Kent Pharma’s 1st transaction in the Life Science sector.
  • This is Kent Pharma’s 1st transaction in Ireland.

M&A Deal Summary

Date 2019-06-05
Target Athlone Laboratories
Sector Life Science
Buyer(s) Kent Pharma
Deal Type Merger

Target

Athlone Laboratories

County Roscommon, Ireland
Athlone Laboratories is a developer and manufacturer of a broad range of oral dose beta-lactam products. Athlone Laboratories was founded in 1974 and is based in County Roscommom, Ireland.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Kent Pharma

Ashford, United Kingdom

Category Company
Founded 1986
Sector Life Science
Revenue 90M EUR (2012)
DESCRIPTION

Kent Pharma is a provider in the development, manufacture, sales, marketing, and distribution of generic pharmaceuticals for the British, Irish and international markets. Kent has a broad portfolio of its own licensed products with a particular focus on beta lactam antibiotics including penicillin V, flucloxacillin and amoxicillin, which are long established antibiotics typically used to treat bacterial infections such as throat, ear and respiratory tract infections. Kent Pharma was founded in 1986 and is based in Ashford, United Kingdom.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
Country: Ireland M&A 1 of 1
Year: 2019 M&A 1 of 1